Charles River Associates

CRA is pleased to announce that #CRAIntellectualProperty's Brian Daniel has been appointed to the INTA Board of Directors for the 2025–2027 term. INTA is a global association of brand owners and professionals dedicated to supporting trademarks and complementary intellectual property (#IP) to foster consumer trust, economic growth, and innovation.

#CRAForensicServices and #CRARiskInvestigations are proud to be recognized in the 2024 Edition of the GIR 100 as a leader in cross-border investigations. Global Investigations Review (GIR) is a leading resource for comprehensive news, analysis, and data on cross-border investigations, offering insights into global trends, government agency actions, and corporate compliance matters, including anti-bribery, financial misconduct, antitrust, and more.

On August 1, 2024, the European Commission initiated a public consultation on its draft guidelines regarding exclusionary abuses of dominance, aiming to align with recent EU court case law and enhance legal clarity for stakeholders. #CRACompetition's Europe consultants contributed by providing comments drawn from extensive experience with Article 102 cases, supporting the goal of clear, practical guidance for all parties involved. The effort was driven by a team including Ugur Akgun, Matthew Bennett, Rapha?l De Coninck, Daniel Donath, Mika?l Hervé, Diana Jackson, Oliver Latham, Matteo Foschi, Samuel Marden, Sara Ross, Domil? Butkevi?iūt?, Christian Michel, Chara Tzanetaki, and Liam Connolly. To learn more, click here: https://crai.news/05s?

Published in PM360, #CRALifeSciences Ashley Fraser and Owen Male explore strategic considerations for manufacturers in their article, “Strategies for Combination Therapy in Oncology – Part Three: Thinking Outside the Box.” The piece addresses the challenges healthcare systems face in valuing incremental clinical improvements in oncology and funding costlier combination regimens. Fraser and Male delve into key hurdles related to pricing, market access, payer value recognition, and price management from the manufacturer’s perspective. As combination therapies expand beyond oncology, manufacturers must proactively shape policies to ensure fair value recognition and a sustainable commercial landscape that supports ongoing innovation. To read the full insights, click here: https://crai.news/8k7 #Oncology

The Annual CRA Brussels Conference is back at the Steigenberger Wiltcher’s Hotel on Tuesday 10 December 2024. This year’s theme is “Regaining Competitiveness: Boom or Bust for Competition Policy?” The event will feature sessions on key topics such as mergers, technology and AI regulation, the evolution of economic analysis in antitrust, the Digital Markets Act (DMA), and more. Visit our website for the full list of speakers, the agenda and to register to join us in Brussels. https://lnkd.in/eQZu-shb #CRACompetition #BrusselsConference #Antitrust

CRA is proud to announce that #CRAForensicServices' Aniket Bhardwaj has been recognized in The Consulting Report’s “Top 25 Cybersecurity Consultants and Leaders of 2024.” This award highlights Aniket’s exceptional ability to help organizations of all sizes navigate the evolving cyber risk landscape. To read more about Aniket’s work, click here: https://lnkd.in/eQ8ZUQnS

#CRACompetition's Serge Moresi?will present his paper, 'Midstream Mergers,' during the Antitrust Economics session at the 94th Annual Meeting of the Southern Economic Association, taking place in Washington, D.C. To learn more about this event, click here: https://crai.news/tr8 #CRASpeaks

Without effective antibiotics, healthcare systems would face significant challenges. Medical procedures could become too dangerous to perform due to the high risk of infections, and by 2050 European healthcare systems would be burdened with an estimated 569 million extra days of hospitalization related to antimicrobial resistance (AMR) annually, significantly impacting care for other patients. In an infographic supporting World AMR Awareness Week, #CRALifeScience’s consultants Steven Kelly and Hannah Armstrong delve into how antibiotics should be viewed as essential infrastructure for healthcare delivery, not just rescue medications. To support this, we must invest in their development and production, maintain a robust supply chain, and ensure patient access. To learn more, click here: https://crai.news/2s2

Are you an undergraduate or graduate student curious about UK Life Sciences policy and strategy consulting? Join Charles River Associates for a virtual Information Session on Wednesday, 27th November at 5:30PM GMT. This event will offer insights into our firm, the work we do, and the recruitment process. Attendees will have the opportunity to engage directly with consultants from our Life Sciences practice and recruiters. This session is designed for students in the UK and Europe pursuing undergraduate or graduate programs who are interested in internship and full-time positions starting in 2025 and beyond. Register now to secure your spot. To RSVP, click here: https://crai.news/bfg #SeeYourselfatCRA #CareersAtCRA

#CRAEnergy's AdequacyX is an AI-driven resource adequacy model that uses Monte Carlo-based loss of load simulations and synthetic data to forecast future grid conditions, including changing load patterns and generator reliability. Our recent Insights underscore the importance of simulating these future load conditions and correlated events. Models that do not consider changing load shapes, cold weather outages, and system evolutions may overlook crucial synergies or misrepresent system adequacy. CRA's approach accurately captures the capacity contributions of various generating technologies and identifies potential reliability risks that could be missed with models based solely on historical data. With advanced tools and market expertise, CRA supports utilities and grid operators in balancing affordability, reliability, and sustainability in their long-term planning. To read the full insights, click here: https://crai.news/zy2 #AI